IBBQ News and Press, Invesco Nasdaq Biotechnology ETF From 05/20/24

2024-05-20 12:55:00 ET Summary New technologies in the biotech sector, particularly in cancer and other disease areas, are driving innovation and investment opportunities. New technologies and innovations may drive the space forward. U.S. election cycle and regulation/policy r...

2024-05-16 09:00:00 ET Summary US managed care providers have been under pressure because of disappointing reimbursement rates from government-backed programs and rising utilization trends. Healthcare stocks have had a weak start in 2024. Like in any sector, some diversified m...

2024-05-16 03:10:00 ET Summary The Fed continues to hold interest rates steady as it focuses on the totality of economic data before it begins to cut rates. Meanwhile, the markets now expect the Fed to cut rates only once toward the latter part of this year. Corporate bond spreads...

2024-04-16 10:30:00 ET Summary The rise in rates last week pushed the 10-year to its highest level since the peak at 5% in October of last year. Gold has been setting new highs, trading above $2400 at one point on Friday before succumbing to some profit taking. Year-to-date, t...

2024-03-22 11:15:00 ET Summary A positive January for U.S. stocks is typically a prelude to a positive year, with our analysis finding the correlation to hold 80% of the time since 1928. Stocks look well-positioned to outperform bonds and cash again this year, but high valuations ...

2024-03-19 10:23:02 ET More on Invesco Nasdaq Biotechnology ETF Seeking Alpha’s Quant Rating on Invesco Nasdaq Biotechnology ETF Dividend scorecard for Invesco Nasdaq Biotechnology ETF Read the full article on Seeking Alpha For further details see: ...

2024-03-13 10:10:00 ET Summary Jeff Hirsch, editor-in-chief of The Stock Trader’s Almanac, and Carter Worth, CEO and founder of Worth Charting, discuss their outlook for 2024 with MoneyShow's Mike Larson. Jeff expects a strong year for stocks, with gains of 8-15% broadly sp...

2024-03-09 03:59:00 ET Summary Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a healthy recovery. Biot...

2024-03-02 16:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-02-23 04:05:00 ET Summary Within healthcare, an area that has been negatively impacted the last couple of years is the pharmaceutical manufacturing value chain. Several capital goods and materials sectors experienced recessionary conditions last year, which caused weak fundam...